CyTOF-based profiling of circulating tumor cells predicts aggressiveness and therapy response in SCLC liquid biopsies at a personalized level
Mukulika Bose, Cole Ruoff, Shafqat Ehsan…·Loukia Georgiou Karacosta
This study uses CyTOF to profile circulating tumor cells in SCLC patients, identifying subtype-specific markers and treatment response correlations.